Next, to identify TF hubs significantly affected on genomic and epigenomic levels in prostate cancer, they are evaluated for the presence of prostate-cancer specific genomic alterations (single nucleotide variants and structural variants) and DNA methylation changes in their coding and non-coding regulatory regions. Here, TF is linked to prostate carcinoma.